ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,394,612, issued on Aug. 19, was assigned to Quest Diagnostics Investments LLC (Secaucus, N.J.).
"Determination of antidepressants by mass spectrometry" was invented by Anita Dermartirosian (Stevenson Ranch, Calif.), Edith Shahbol (Northridge, Calif.), Karin Thomassian (Tujunga, Calif.), Shaun Rezaei (Santa Clarita, Calif.) and Asad Shah (Sylmar, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for detecting or determining an amount of one or more serotonin and norepinephrine reuptake inhibitors (SNRI) and SNRI metabolites in a sample by tandem mass spectrometry includes subjecting the sample to ionization under conditions suitable to produ...